menu
    • menu

    Company profile for BIOVICA INTERNATIONAL AB

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Biovica, a Swedish biotech company founded in 2009, develops and commercializes blood-based biomarker assays that improve the monitoring of modern cancer therapies and better predict patient outcome. Our initial focus is breast cancer, where approximately 1600 new cases are diagnosed every day in the EU and US alone. By collaborating with world-leading cancer institutes as well as pharmaceutical companies launching next-genera...
    Biovica, a Swedish biotech company founded in 2009, develops and commercializes blood-based biomarker assays that improve the monitoring of modern cancer therapies and better predict patient outcome. Our initial focus is breast cancer, where approximately 1600 new cases are diagnosed every day in the EU and US alone. By collaborating with world-leading cancer institutes as well as pharmaceutical companies launching next-generation therapies, we actively promote the growing drive towards personalized medicine. Improved patient survival plus lower healthcare costs are two anticipated and welcome outcomes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BIOVICA INTERNATIONAL ABSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Dag Hammarskjölds väg 54B Uppsala Science Park 752 37 Uppsala
    Telephone
    Telephone
    +46 (0) 18 44 44 830
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://biovica.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/biovica-international-ab
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/hashtag/biovica

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PCHi

    PCHi

    Not Confirmed

    envelop Contact Supplier

    PCHi

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biovica International AB: Q3 Interim Report, Nov 2025–Jan 2026
    Biovica International AB: Q3 Interim Report, Nov 2025–Jan 2026

    18 Mar 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/biovica-international-ab-q3-interim-report-nov-2025-jan2026-1148803

    ACCESSWIRE
    18 Mar 2026
    Share Share
    Biovica International AB - Q2 Interim report Aug - Oct 2025
    Biovica International AB - Q2 Interim report Aug - Oct 2025

    18 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-18/biovica-international-ab-q2-interim-report-aug-oct-2025

    PHARMIWEB
    18 Dec 2025
    Share Share
    Biovica Inks Client Bill Deal With Top U.S. Cancer Center
    Biovica Inks Client Bill Deal With Top U.S. Cancer Center

    15 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-15/biovica-signs-client-bill-agreement-with-leading-us-nci-designated-cancer-center

    PHARMIWEB
    15 Dec 2025
    Share Share
    Two New Studies With Divitum Tka Presented At SABCS 2025
    Two New Studies With Divitum Tka Presented At SABCS 2025

    26 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-26/two-new-studies-with-divitum-tka-presented-at-sabcs-2025

    PHARMIWEB
    26 Nov 2025
    Share Share
    Biovica's Q1 Interim Report: May-July 2025
    Biovica's Q1 Interim Report: May-July 2025

    11 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-11/biovica-q1-interim-report-may-2025-july-2025

    PHARMAWEB
    11 Sep 2025
    Share Share
    Annual General Meeting Notice for Biovica International AB
    Annual General Meeting Notice for Biovica International AB

    22 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-22/notice-of-annual-general-meeting-in-biovica-international-ab

    PHARMAWEB
    22 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search